1210 Enhancing the Therapeutic Efficacy of Immune Checkpoint Inhibition and Targeted Therapy Using Anti-Tumor Antibodies in Mouse Melanoma

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.1225
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Association of First-In-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma

JAMA Oncology
Cancer ResearchOncology
2018English

The FG Loop of PD-1 Serves as a ‘Hot-Spot’ for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy

iScience
Multidisciplinary
2019English

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy

Frontiers in Immunology
AllergyImmunology
2020English

On the Mechanism of Anti-Cd39 Immune Checkpoint Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

839 Dual Targeting Autoinflammation and PD-L1/L2 Immune Checkpoint by EGCG Augments Anti-Tumor Effects in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

A Novel Immunogenic Mouse Model of Melanoma for the Preclinical Assessment of Combination Targeted and Immune-Based Therapy

Scientific Reports
Multidisciplinary
2019English

Evaluation of Therapeutic Effect of Tumor-Targeted Therapy

OncoTargets and Therapy
OncologyPharmacology
2012English

Efficacy and Safety of Immune Checkpoint Therapy in Hepatocellular Carcinoma: Meta-Analysis

Hepatoma Research
2019English

Enhancing the Therapeutic Effects of in Vitro Targeted Radionuclide Therapy of 3D Multicellular Tumor Spheroids Using the Novel Stapled MDM2/X-p53 Antagonist PM2

EJNMMI Research
Nuclear MedicineRadiologyImaging
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy